About this item:

11 Views | 8 Downloads

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Critical Care Medicine
  • Respiratory System
  • General & Internal Medicine

Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an Open-Label Phase 3 Clinical Trial

Show all authors Show less authors

Tools:

Journal Title:

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Volume:

Volume 203, Number 3

Publisher:

, Pages 381-385

Type of Work:

Article

Abstract:

None
Export to EndNote